Form 4 for LLY Lilly (Eli)
Accepted 2023-12-04 00:00:00 ET · period of report 2023-12-01 · accession 0000059478-23-000316 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-04 | 2023-12-01 | LLY | Zakrowski Donald A | SVP, CAO, Fin | F - Tax | $591.04 | -2,142 | 7,376 | -23% | -$1.27M |
| D | 2023-12-04 | 2023-12-01 | LLY | Zakrowski Donald A | SVP, CAO, Fin | M - OptEx | $0.00 | +4,810 | 9,518 | +102% | $0 |
| D | 2023-12-04 | 2023-12-01 | LLY | Zakrowski Donald A | SVP, CAO, Fin | M - OptEx | $0.00 | -4,810 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | F | D | 2,142 | $591.04 | 7,376 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-01 | M | A | 4,810 | $0.00 | 9,518 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-12-01 | M | D | 4,810 | $0.00 | 0 | D | — · 2023-12-01 to 2023-12-01 | 4,810 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |